Oslo, Norway

Jonny Ostensen


Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 35(Granted Patents)


Company Filing History:


Years Active: 1997-2011

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Jonny Ostensen: Innovator in Cardiac Imaging Technology

Introduction

Jonny Ostensen is a notable inventor based in Oslo, Norway. He has made significant contributions to the field of cardiac imaging technology, holding two patents that focus on innovative methods to improve cardiac health assessments.

Latest Patents

Ostensen's latest patents include an ultrasound triggering method designed to reduce cardiac arrhythmia. This invention relates to a triggered ultrasound imaging method for visualizing the myocardium, which minimizes the risk of eliciting cardiac arrhythmia. The method assesses cardiac perfusion by triggering destruction pulses within the heart's refractory period while imaging pulses are activated at any point in the ECG cycle, preferably during end-systole. Another patent involves ultrasound imaging that utilizes temporal variations in backscatter from an ultrasound contrast agent in the vascular system. This technique visualizes the presence of the contrast agent by identifying areas with poor correlation between successive ultrasound images, allowing for the distinction between stationary and moving bulk tissue.

Career Highlights

Throughout his career, Jonny Ostensen has worked with prominent companies in the medical imaging sector, including Nycomed Imaging AS and GE Healthcare AS. His work has significantly advanced the capabilities of cardiac imaging technologies.

Collaborations

Ostensen has collaborated with notable professionals in his field, including Morton Eriksen and Lars Hoff. Their combined expertise has contributed to the development of innovative solutions in cardiac imaging.

Conclusion

Jonny Ostensen's contributions to cardiac imaging technology through his patents and collaborations highlight his role as a key innovator in the medical field. His work continues to impact the assessment and treatment of cardiac conditions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…